Skip to content
Back to the Guavy Wire
Stocks

GSK Transfers Millions of Shares for Employee Compensation Plans

Instruments
JPM
Share

GlaxoSmithKline (GSK) has completed a significant transfer of shares to support its employee compensation plans. On November 20, 2026, the company moved 22,000,000 treasury-held ordinary shares to JPMorgan Chase Bank, N.A., the depositary for its American depositary receipts (ADRs) program. This transfer was intended to issue and transfer 11,000,000 ADRs to the GlaxoSmithKline (US) Trust, which will be used to fulfill awards under various employee incentive plans, including the Deferred Annual Bonus Plan, Performance Share Plan, and Share Value Plan.

The transaction was valued at $47.82 per ADR, equivalent to $23.91 per ordinary share. Funding for the transfer came from a contribution by GlaxoSmithKline LLC to the Trust. Following the transfer, GSK will retain 248,881,064 ordinary shares in treasury, with a total of 4,067,451,066 ordinary shares in issue, excluding treasury shares. Treasury shares will now represent 6.12% of voting rights.

Analysts have recently rated GSK stock as a Hold, with a price target of $55.90. Spark, TipRanks’ AI Analyst, has labeled GSK as Neutral, citing strong financial performance, constructive earnings updates, and a supportive valuation with a mid-teens P/E and a ~3.7% dividend yield. However, technical indicators remain a headwind, as the stock trades below key longer-term moving averages.

GSK is a global biopharma company focused on uniting science, technology, and talent to combat disease. The company’s current market capitalization stands at $95.84 billion, with an average trading volume of 4,022,508 shares.

More on Stocks